MD Anderson Cancer Center
Targeted drug helps Hodgkin lymphoma patients – CNL
An antibody that homes to malignant cells unloads a toxic cargo inside them. Phase I trial shows remissions in patients with resistant or recurring disease.

Accessibility shortcut keys (H) Shortcuts    
Video is loading...
Title: Targeted drug helps Hodgkin lymphoma patients – CNL
Summary: An antibody that homes to malignant cells unloads a toxic cargo inside them. Phase I trial shows remissions in patients with resistant or recurring disease.
Keywords: State of the Institution, MD Anderson, Mendelsohn
Transcript: